Sodium Gluconate, Gluconic Acid, and Derivative Products From the People's Republic of China: Preliminary Determination of Sales at Less Than Fair Value
Commerce Department; International Trade Administration · 2018
Read Sodium Gluconate, Gluconic Acid, and Derivative Products From the People's Republic of China: Preliminary Determination of Sales at Less Than Fair Value by Commerce Department; International Trade Administration (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/uslaw-fr-2018-14729.txt.
Description
Notice published in the Federal Register on 2018-07-10 by Commerce Department; International Trade Administration. Text from federalregister.gov (official edition: govinfo). [Pages 31949-31951] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2018-14729] ----------------------------------------------------------------------- DEPARTMENT OF COMMERCE International Trade Administration [A-570-071] Sodium Gluconate, Gluconic Acid, and Derivative Products From the People's Republic of China: Preliminary Determination of Sales at Less Than Fair Value AGENCY: Enforcement and Compliance, International.
Catalog record
| CREATOR | Commerce Department; International Trade Administration |
|---|---|
| YEAR | 2018 |
| COLLECTION | LAW |
| FORMAT | TXT |
| FILE SIZE | 21 KB |
| VERSION | 1.0 |
| LICENSE | Public Domain |
| RIGHTS | PUBLIC DOMAIN |
| SOURCE | Federal Register |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Sodium Gluconate, Gluconic Acid, and Derivative Products From the People's Republic of China: Preliminary Determination of Sales at Less Than Fair Value Citation: us:fr:2018-14729 Creator: Commerce Department; International Trade Administration Year: 2018 Source-URL: https://www.federalregister.gov/documents/2018/07/10/2018-14729/sodium-gluconate-gluconic-acid-and-derivative-products-from-the-peoples-republic-of-china Context: Notice published in the Federal Register on 2018-07-10 by Commerce Department; International Trade Administration. Text from federalregister.gov (official edition: govinfo). [Pages 31949-31951] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 2018-14729] ----------------------------------------------------------------------- DEPARTMENT OF COMMERCE International Trade Administration [A-570-071] Sodium Gluconate, Gluconic Acid, and Derivative Products From the People's Republic of China: Preliminary Determination of Sales at Less Than Fair Value AGENCY: Enforcement and Compliance, International Trade Administration, Department of Commerce. SUMMARY: The U.S. Department of Commerce (Commerce) preliminarily determines that sodium gluconate, gluconic acid, and derivative products from the People's Republic of China (China) are, or are likely to be, sold in the United States at less than fair value (LTFV). The period of investigation (POI) is April 1, 2017, through September 30, 2017. Interested parties are invited to comment on this preliminary determination. DATES: Applicable July 10, 2018. FOR FURTHER INFORMATION CONTACT: Magd Zalok or Stephen Bailey, AD/CVD Operations, Office IV, Enforcement & Compliance, International Trade Administration, Department of Commerce, 1401 Constitution Avenue NW, Washington, DC 20230; telephone: (202) 482-4162 or (202) 482-0193 respectively. SUPPLEMENTARY INFORMATION: Background This preliminary determination is in accordance with section 733(b) of the Tariff Act of 1930, as amended (the Act). Commerce published the notice of initiation of this investigation on January 4, 2018.\1\ On May 1, 2018, Commerce postponed the preliminary determination of this investigation.\2\ Commerce has exercised its discretion to toll deadlines for the duration of the closure of the Federal Government from January 20 through 22, 2018.\3\ The revised deadline for the preliminary determination for this investigation is now July 2, 2018. --------------------------------------------------------------------------- \1\ See Sodium Gluconate, Gluconic Acid, and Derivative Products from France and the People's Republic of China: Initiation of Less- Than-Fair-Value Investigations, 83 FR 516 (January 4, 2018) (Initiation Notice). \2\ See Sodium Gluconate, Gluconic Acid, and Derivative Products from the People's Republic of China: Postponement of Preliminary Determination in the Less-Than-Fair-Value Investigation, 83 FR 19050 (May 1, 2018). \3\ See Memorandum, for The Record from Christian Marsh, Deputy Assistant Secretary for Enforcement and Compliance, performing the non-exclusive functions and duties of the Assistant Secretary for Enforcement and Compliance, ``Deadlines Affected by the Shutdown of the Federal Government,'' (Tolling Memorandum), dated January 23, 2018. All deadlines in this segment of the proceeding have been extended by 3 days. --------------------------------------------------------------------------- For a complete description of the events that followed the initiation of this investigation, see the Preliminary Decision Memorandum.\4\ A list of topics included in the Preliminary Decision Memorandum is included as Appendix II to this notice. The Preliminary Decision Memorandum is a public document and is on file electronically via Enforcement and Compliance's Antidumping and Countervailing Duty Centralized Electronic Service System (ACCESS). ACCESS is available to registered users at https://access.trade.gov, and to all parties in the Central Records Unit, room B8024 of the main Department of Commerce building. In addition, a complete version of the Preliminary Decision Memorandum can be accessed directly at http://enforcement.trade.gov/frn/. The signed and the electronic versions of the Preliminary Decision Memorandum are identical in content. --------------------------------------------------------------------------- \4\ See Memorandum, ``Decision Memorandum for the Preliminary Determination of the Less-Than-Fair-Value Investigation of Sodium Gluconate, Gluconic Acid, and Derivative Products from People's Republic of China (Preliminary Decision Memorandum), dated concurrently with, and hereby adopted by, this notice. See also Appendix I. --------------------------------------------------------------------------- Scope of the Investigation The products covered by this investigation are sodium gluconate, gluconic acid, and derivative products from China. For a complete description of the scope of this investigation, see Appendix I to this notice. Scope Comments In accordance with the preamble to Commerce's regulations,\5\ the Initiation Notice set aside a period of time for parties to raise issues regarding product coverage (scope).\6\ On January 9, 2018, and January 19, 2018, Commerce received scope comments and rebuttal comments, respectively.\7\ For further details, see the Preliminary Decision Memorandum accompanying this notice. However, Commerce is not preliminarily modifying the scope language as it appeared in the Initiation Notice. See the scope in Appendix I to this notice. --------------------------------------------------------------------------- \5\ See Antidumping Duties; Countervailing Duties, 62 FR 27296, 27323 (May 19, 1997). \6\ See Initiation Notice. \7\ See Letter from Jungbunzlauer S.A. to Commerce, ``Investigations Sodium Gluconate, Gluconic Acid, and Derivative Products from France and China--Junsbunzlauers Comments regarding Scope,'' dated January 9, 2018, and PMP's Letter to Commerce, ``Countervailing and Antidumping Duty Investigation of Sodium Gluconate, Gluconic Acid and Derivative Products from the People's Republic of China: Petitioner's Rebuttal Comments on Scope Comments,'' dated January 19, 2018. --------------------------------------------------------------------------- Methodology Commerce is conducting this investigation in accordance with section 731 of the Act. Pursuant to sections 776(a) and (b) of the Act, Commerce preliminarily has relied upon facts otherwise available, with adverse inferences, for the China-wide entity. The China-wide entity includes mandatory respondents Shandong Fuyang Biotechnology Co., Ltd./ Shandong Fuyang Biology Starch Co., Ltd. (Shandong Fuyang) \8\ Qingdao [[Page 31950]] Dongxiao Enterprise Co., Ltd. (Qingdao Dongxiao),\9\ Zhejiang Tianyi Food Additives Co., Ltd. (Tianyi Food) \10\ and Dezhou Huiyang Biotechnology Co., Ltd. (Dezhou Huiyang).\11\ These companies failed to respond to Commerce's requests for information and withdrew from participation in this investigation. For a full description of the methodology underlying Commerce's preliminary determination, see the Preliminary Decision Memorandum. --------------------------------------------------------------------------- \8\ See Memorandum, ``Less-Than-Fair-Value Investigation of Sodium Gluconate, Gluconic Acid, and Derivative Products from the People's Republic of China: Respondent Selection,'' dated January 17, 2018 (Initial Respondent Selection Memorandum). See also Shandong Fuyang letter, ``Notice of Non-Participation in Investigation,'' dated March 30, 2018. \9\ See Qingdao Dongxiao, see the Initial Respondent Selection Memorandum and Qingdao Dongxiao's Letter, ``Withdrawal from Participation,'' dated February 14, 2018. \10\ See Tianyi Food, see Commerce's Memorandum, ``Selection of Additional Respondent,'' dated March 5, 2018 and Tianyi Food's Letter, ``Withdrawal from Participation,'' dated March 8, 2018. \11\ See Dezhou Huiyang's Commerce's Memorandum, ``Selection of Additional Respondent,'' dated March 9, 2018 and Dezhou Huiyang's Letter, ``Dezhou Huiyang Biotechnology Co., Ltd. Withdrawal of Participation in Antidumping Duty Investigation,'' dated March 13, 2018. --------------------------------------------------------------------------- Separate Rate In proceedings involving NME countries, Commerce maintains a rebuttable presumption that all companies within the country are subject to government control and, therefore, should be assessed a single weighted-average dumping margin.\12\ Commerce's policy is to assign all exporters of subject merchandise that are in an NME country this single rate unless an exporter can demonstrate that it is sufficiently independent so as to be entitled to a separate rate.\13\ Commerce preliminarily finds that the evidence placed on the record of this investigation by Anhui Xingzhou Medicine Food Co., Ltd. (Xingzhou Medicine) \14\ demonstrates an absence of de jure and de facto government control. Commerce assigned Xingzhou Medicine a separate rate, which is the petition rate, because it is the only rate available on the record of this proceeding. For a full description of the methodology underlying Commerce's preliminary determination, see the Preliminary Decision Memorandum. --------------------------------------------------------------------------- \12\ See, e.g., Polyethylene Terephthalate Film, Sheet, and Strip from the People's Republic of China: Final Determination of Sales at Less Than Fair Value, 73 FR 55039,